Jefferies Financial Group Inc.
A top-tier independent financial advisor offering global capital markets solutions, M&A advisory, and specialized equity research services to institutional and corporate clients.
A top-tier independent financial advisor offering global capital markets solutions, M&A advisory, and specialized equity research services to institutional and corporate clients.
JEF offers attractive exposure to the independent securities business model with significant revenue growth momentum and a robust capital base supporting continued market share gains. The company's specialized niche in complex transactions combined with strong trading profitability creates a durable earnings profile that should outperform broader financial peers during economic expansions.
Investors should consider elevated operating expenses relative to revenue margins and potential headwinds from reduced M&A deal flow in certain sectors. Regulatory uncertainty and interest rate sensitivity could compress net interest income, while the substantial retained earnings deficit of $8.57B indicates ongoing capital management challenges that warrant close monitoring.
Jefferies Financial Group Inc. (JEF) is a leading independent global securities firm providing comprehensive investment banking, sales & trading, and asset management services to corporations, governments, and institutional clients worldwide. The company generates revenue primarily through underwriting, advisory fees, proprietary trading, and client assets under administration across its investment banking and wealth management segments.
Recent financial performance shows strong revenue growth to $10.82B in 2025 from $7.44B in 2023, reflecting successful expansion in investment banking and trading operations. Net income of $682M demonstrates resilience despite elevated operating expenses of $9.76B, with healthy cash positions totaling $14.04B providing flexibility for strategic initiatives.
The independent securities industry serves as a critical intermediary between capital providers and seekers, with revenue heavily dependent on market liquidity, corporate deal activity, and client asset flows. Firms compete on expertise, research quality, and technology platforms while navigating evolving regulatory landscapes that shape business models across investment banking and wealth management.
| Metric | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Revenue | $7.15B | $7.44B | $10.52B | $10.82B |
| Cost of Revenue | $440.8M | $29.4M | $206.3M | $190.9M |
| Gross Profit | $6.71B | $7.41B | $10.31B | $10.63B |
| Operating Expenses | $5.65B | $7.06B | $9.30B | $9.76B |
| Operating Income | $1.06B | $354.3M | $1.01B | $871.0M |
| Stock-Based Comp | $43.9M | $45.4M | $63.1M | $88.2M |
| D&A | $172.9M | $112.2M | $190.3M | $192.3M |
| Amortization | $10.9M | $9.3M | $30.3M | $33.5M |
| Non-Operating Income | $0 | $0 | $0 | $0 |
| Interest Expense | $1.17B | $2.74B | — | — |
| Interest Income | — | — | $3.1M | $1.0M |
| Pre-Tax Income | $1.06B | $354.3M | $1.01B | $871.0M |
| Income Tax | $273.9M | $91.9M | $293.2M | $184.6M |
| Continuing Ops | $781.7M | $262.4M | $712.4M | $686.4M |
| Discontinued Ops | $0 | $0 | $3.7M | $-4.4M |
| Net Income | $781.7M | $262.4M | $716.0M | $682.0M |
| Minority Interest | $-2.4M | $0 | $0 | $0 |
| Net to Common | $784.1M | $262.4M | $716.0M | $682.0M |
| Metric | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Cash & Equivalents | $9.70B | $8.53B | $12.15B | $14.04B |
| Intangibles | $139.5M | $196.9M | $226.4M | $202.6M |
| Goodwill | $1.74B | $1.85B | $1.83B | $1.84B |
| Operating Leases | $455.3M | $455.5M | $553.8M | $525.7M |
| Total Assets | $51.06B | $57.91B | $64.36B | $76.01B |
| Deferred Revenue | $27.0M | $48.3M | $79.1M | $92.3M |
| Total Liabilities | $40.63B | $48.10B | $54.13B | $65.37B |
| Shareholders' Equity | $10.43B | $9.80B | $10.22B | $10.64B |
| Retained Earnings | $8.42B | $7.85B | $8.27B | $8.57B |
| AOCI | $-379.4M | $-395.5M | $-423.1M | $-384.4M |
| Total L&E | $51.06B | $57.91B | $64.36B | $76.01B |
| Metric | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Net Income (CFO) | $781.7M | $262.4M | $716.0M | $682.0M |
| Non-Cash Adjustments | $6.55B | $-13.27B | $-7.12B | $-17.89B |
| Working Capital Changes | $-5.53B | $11.07B | $6.19B | $15.71B |
| Cash from Operations | $1.80B | $-1.93B | $-209.3M | $-1.50B |
| Capital Expenditures | $224.3M | $1.2M | $250.6M | $207.5M |
| Cash from Investing | $-60.5M | $-12.2M | $210.3M | $-298.8M |
| Debt Repayments | $824.9M | $1.28B | $2.43B | $4.06B |
| Share Buybacks | $859.6M | $169.4M | $44.3M | $58.5M |
| Dividends Paid | $280.1M | $278.6M | $303.0M | $374.1M |
| Cash from Financing | $-2.84B | $1.06B | $3.35B | $3.59B |
| FX Effect | $-22.1M | $54.9M | $-2.2M | $2.4M |
| Net Change in Cash | $-1.12B | $-830.8M | $3.35B | $1.80B |
| Beginning Cash | $11.83B | $10.71B | $9.83B | $13.17B |
| Ending Cash | $10.71B | $9.83B | $13.17B | $14.96B |
The firm's revenue is driven by Investment Banking (M&A advisory, capital raising), Sales & Trading (market-making, proprietary trading, brokerage services), and Asset Management (wealth management, private client services). Additional segments include Capital Markets operations including Prime Services and Structured Finance divisions that serve diverse institutional needs.
Regulatory changes affecting capital requirements and market-making activities, volatility in interest rates impacting net interest income and client borrowing costs, concentration risk in specific sectors or geographies affecting underwriting pipelines, and potential slowdowns in M&A activity reducing advisory fee revenue.
Jefferies maintains a competitive edge through its status as an independent boutique with deep specialization in complex transactions, a highly regarded equity research platform that drives trading flow, and strong relationships with mid-cap and growth-oriented corporate clients seeking unbiased advice.
Not financial advice. All content is for informational purposes only. Data may contain errors. Consult a qualified financial advisor before making investment decisions.